AzTrials
AzTrials

Alcohol DrinkingSTARNCT03401333

Brief Interventions With Text Messaging to Reduce Adolescent Alcohol and Marijuana Use

A study testing Text Messaging and Brief Negotiation Interview in people with Alcohol Drinking and Marijuana, run by Yale University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study tests the feasibility of an intervention to prevent risky alcohol or marijuana use that adds a 4-week course of tailored text messaging to a brief motivational intervention for 13-18-year-old adolescents. Read more about this study

Who is it for?
Ages 13 to 18 yearsHealthy volunteers can take part
Conditions the study is for
Alcohol Drinking, Marijuana
What is being tested?
Text Messaging and Brief Negotiation Interview
Could I receive a placebo?
No, everyone receives an active treatment
How many people
10 participants
Where
1 siteUnited States
Study dates
14 Nov 2017to 6 Jun 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 13 to 18 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • 13 to 18 years old
  • Able to provide consent or assent and parental permission
  • have a functioning cell phone without pay-as-you-go text messaging

Who cannot join

  • currently enrolled in any substance abuse program;
  • have medical/psychiatric condition that precludes participation

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Yale New Haven Hospital

    New Haven, Connecticut, 06520

Other trials in United States

About this study

Official title: Feasibility of Augmenting Brief Interventions With Text Messaging to Reduce Adolescent Alcohol and Marijuana Use

This study tests the feasibility of an intervention to prevent risky alcohol or marijuana use that adds a 4-week course of tailored text messaging to a brief motivational intervention for 13-18-year-old adolescents.

Being tested
Text Messaging and Brief Negotiation Interview
Medical subject headings
Alcohol Drinking, Marijuana Abuse

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Text Messaging and Brief Negotiation InterviewBehavioural

    An in-person brief motivational intervention coupled with 4 weeks of motivational text messages

Study groups in NCT03401333
Study groupRoleWhat they receive
Text messaging and brief interventionExperimentalBrief motivational interview and 4-weeks of text messaging.
Receives: Behavioral: Text Messaging and Brief Negotiation Interview

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Enrollment

    Number of participants per month that enroll in the study

    Measured: Baseline

  2. Retention

    % of enrolled participants that complete the 4-week follow up assessments

    Measured: 4 weeks

  3. Satisfaction

    Participant's rating of how much they like the intervention (Likert scale)

    Measured: 4 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Jan 2018
  2. Study start14 Nov 2017
  3. Primary completion6 Jun 2018
  4. Study completion6 Jun 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Model description
A brief motivational interview and four weeks of text messaging.
Masking
None (open label)
Enrolment
10 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03401333
Sponsor's protocol ID
2000021254
Acronym
STAR
Status last verified
Oct 2018
First submitted
9 Jan 2018
Last updated
23 Oct 2018
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: IPD will not be shared

Questions about this trial

What is this clinical trial studying?

A study testing Text Messaging and Brief Negotiation Interview in people with Alcohol Drinking and Marijuana, run by Yale University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Oct 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Enrollment (time frame: Baseline). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Oct 2018; AzTrials last refreshed its copy on 1 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in